What is the recommended treatment for a 13-year-old patient with bloody diarrhea due to Campylobacter infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Campylobacter Infection in a 13-Year-Old with Bloody Diarrhea

Azithromycin is the first-line treatment for this 13-year-old patient with bloody diarrhea due to confirmed Campylobacter infection, at a dose of 20-30 mg/kg as a single dose. 1

Rationale for Antimicrobial Therapy

Antimicrobial therapy is indicated in this case because:

  • The patient has confirmed Campylobacter infection with bloody diarrhea
  • Early treatment (within 72 hours of symptom onset) can significantly reduce symptom duration and prevent complications 1
  • Azithromycin has emerged as the preferred first-line therapy due to increasing fluoroquinolone resistance worldwide 1

Treatment Regimen

First-line therapy:

  • Azithromycin: 20-30 mg/kg as a single dose 1
    • Alternative regimen: 10 mg/kg/day for 3 days

Alternative options (if azithromycin unavailable or contraindicated):

  • Ciprofloxacin: Not recommended as first-line in pediatric patients due to:
    • Increasing fluoroquinolone resistance in Campylobacter worldwide 1
    • Concerns about adverse effects on joints and surrounding tissues in pediatric patients 2

Supportive Care

  • Fluid replacement: Reduced osmolarity oral rehydration solution (ORS) is recommended as first-line therapy for mild to moderate dehydration 3
  • Nutrition: Continue age-appropriate diet during or immediately after rehydration 3
  • Avoid antimotility agents: Antimotility drugs (e.g., loperamide) should not be given to children <18 years with acute diarrhea 3

Monitoring and Follow-up

  • Monitor for:
    • Worsening symptoms (increasing fever, bloody stools, severe abdominal pain)
    • Signs of dehydration
    • Response to treatment
  • If symptoms persist beyond 14 days, consider non-infectious conditions including inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) 3

Special Considerations

  • Antibiotic resistance: Fluoroquinolone-resistant Campylobacter is increasingly prevalent worldwide, making azithromycin the preferred choice 1
  • Timing of treatment: Antimicrobial therapy is most beneficial when started early in the illness course (within 72 hours of symptom onset) 1
  • Potential complications: Monitor for rare complications such as reactive arthritis 1

Prevention of Transmission

  • Emphasize proper hand hygiene after using the toilet and before preparing or eating food 3
  • The patient should not return to school until symptoms resolve to prevent transmission 3
  • Asymptomatic contacts do not need treatment but should be advised to follow appropriate infection prevention measures 3

Pitfalls to Avoid

  • Do not confuse Campylobacter infection with Shiga toxin-producing E. coli infection, as antibiotics may increase the risk of hemolytic uremic syndrome in the latter 1
  • Avoid fluoroquinolones as first-line therapy due to increasing resistance rates and concerns about adverse effects in pediatric patients 1, 2
  • Do not use antimotility agents in pediatric patients with acute diarrhea 3

References

Guideline

Campylobacter Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.